Merck ties up with Thermo Fisher to make its COVID-19 pill in Canada

Drugmaker Merck & Co on Monday announced a deal with Thermo Fisher Scientific to manufacture its experimental COVID-19 pill at the medical device maker's site in Whitby, Ontario. The site will manufacture the pill, molnupiravir, for distribution in Canada and the United Kingdom as well as markets in the European Union, Asia Pacific and Latin America. The Ontario site is one of three manufacturing sites in the world for the pill, which is being developed with Ridgeback Biotherapeutics.